Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03621904
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
Sponsor: Radboud University Medical Center
View on ClinicalTrials.gov
Summary
The PROMOTE study aims at optimising use of hormonal therapy in advanced stage and recurrent endometrial cancer analysing tumor tissue taken before start of hormonal therapy
Key Details
Gender
FEMALE
Age Range
18 Years - 110 Years
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2022-10-15
Completion Date
2027-09-01
Last Updated
2023-01-18
Healthy Volunteers
No
Interventions
DRUG
Hormonal Antineoplastics
Hormonal therapy used for treatment in endometrial cancer patients
Locations (1)
Radboudumc
Nijmegen, Netherlands